Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

August 8, 2022
Otsuka Pharmaceutical

Presentation of Research Regarding Compounds Contributing to Alleviation of Premenstrual Symptoms
August 5, 2022
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference
July 29, 2022
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of October 1, 2022
July 29, 2022
Taiho Pharmaceutical

PITAS Throat Troche Series Now Available Outside Japan　- To Ease Your Throat Discomfort Without Being Noticed
July 29, 2022
Taiho Pharmaceutical

大鵬薬品　「ピタスのどトローチシリーズ」を海外展開　周りに気づかれずにケアしたい、のどの不快感に
July 28, 2022
Taiho Pharmaceutical

Taiho Pharmaceutical Submits New Drug Application of FGFR inhibitor futibatinib (TAS-120) for Biliary Tract Cancer
July 26, 2022
Otsuka Medical Devices

Otsuka Medical Devices and ReCor Medical Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System
July 22, 2022
Otsuka Pharmaceutical

Otsuka receives positive CHMP opinion for Lupkynis (voclosporin) for the treatment of active lupus nephritis
July 14, 2022
Otsuka Pharmaceutical

Introducing New B240 Tablets Effortless way to consume a unique ingredient for maintenance of physical condition
July 7, 2022
Otsuka Pharmaceutical

Full-scale Launch of “Kenkokeiei Tsunagaru Support” Service Otsuka Pharmaceutical Supports Resolution of Health Issues for Small & Medium-sized Enterprises
July 5, 2022
Otsuka Foods

Otsuka Foods Zero Meat Features Characters from Fujiko F. Fujio Universe Introducing New Food Culture to Children Also Available at Cafe Menu at Fujiko F. Fujio Museum in Kawasaki
July 1, 2022
Taiho Pharmaceutical

Taiho Pharmaceutical to Provide Matching Funds to Select Crowdfunded Projects Addressing Issues in the Field of Oncology the Second “Taiho Smile Support”
June 30, 2022
Otsuka Pharmaceutical

POCARI SWEAT 250ml Returnable Bottle For Distribution via Circular Shopping Platform ‘Loop’
June 28, 2022
Otsuka Foods

Otsuka Foods Obtains JAS Certification for Soy Meat Foods for Zero Meat Ham and Sausage Retail Products, Adding to Previously Certified Hamburger Products
June 27, 2022
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Lundbeck announce positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole
June 20, 2022
Taiho Pharmaceutical

Taiho Pharmaceutical Obtains Approval to Manufacture and Market HSP90 inhibitor Jeselhy® Tablets 40 mg (Pimitespib) for Gastrointestinal Stromal Tumor (GIST)
June 17, 2022
Otsuka Pharmaceutical

European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with Aripiprazole
June 15, 2022
Otsuka Pharmaceutical

Otsuka Obtains Approval in Japan for Auto-Injector Dosage Form for AJOVY Subcutaneous Injection 225 mg for Preventive Treatment of Migraine
June 13, 2022
Otsuka Pharmaceutical

Otsuka Enters Collaboration with xForest Therapeutics on RNA Structure- Targeted Drug Discovery Covering Multiple Diseases
June 7, 2022
Otsuka Pharmaceutical

Otsuka Pharmaceutical Publishes Paper Investigating Binding Property of Salivary IgA on Pathogenic Microorganisms
June 2, 2022
Otsuka HoldingsOtsuka Chemical

Otsuka Chemical (India) Builds Large Solar Power Generation Facility -Reducing annual CO2 emissions by approximately 14,000 tons-
June 1, 2022
Taiho Pharmaceutical

Taiho Pharmaceutical to Donate a Total of 4.17 Million Yen to Three Projects Addressing Issues in the Field of Oncology "The First Taiho Smile Support"
June 1, 2022
Otsuka Pharmaceutical

Launch in Japan of Moizerto® Ointment, a Treatment for Atopic Dermatitis
May 31, 2022
Otsuka Holdings

Otsuka Group Establishes a New Integrated Energy Service Structure -Contribute to a decarbonized society through collaboration among group companies -
May 31, 2022
Otsuka Foods

Otsuka Foods’ “Zero Meat” to Be Used in Three Vegetable Pasta Dishes on the Grand Menu at All 89 Popolamama Restaurants Starting June 1, 2022
May 30, 2022
Otsuka Pharmaceutical

POCARI SWEAT × TOKUSHIMA VORTIS Football Dream Project Otsuka and Tokushima Vortis collaborate to support overseas promotion of health through sports activities and regional vitalization in Tokushima
May 30, 2022
Otsuka Pharmaceutical

Launch in Japan of SAMTASU® for IV Infusion, a V2 -Receptor Antagonist for the Treatment of Cardiac Edema
May 25, 2022
Taiho Pharmaceutical

Taiho Pharmaceutical Announces the Launch of Selective NK1 Receptor Antagonist Arokaris® I.V. Infusion 235mg in Japan
May 23, 2022
Otsuka Foods

Otsuka Foods Obtains Japan’s First JAS Certification for Soy Meat Foods for Two Zero Meat Retail Products
May 18, 2022
Otsuka Medical Devices

Announced Results of Pooled Data Analysis from RADIANCE SOLO and TRIO Studies in Treating Hypertension with the Paradise™ Ultrasound Renal Denervation System

Otsuka Group News

First 30 results